VCEL has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
VCEL has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Vericel's Other Stockholders Equity for the quarter that ended in Dec. 2024 was $-0.0 Mil.
Vericel's quarterly Other Stockholders Equity stayed the same from Jun. 2024 ($0.0 Mil) to Sep. 2024 ($0.0 Mil) but then declined from Sep. 2024 ($0.0 Mil) to Dec. 2024 ($-0.0 Mil).
Vericel's annual Other Stockholders Equity declined from Dec. 2022 ($0.0 Mil) to Dec. 2023 ($-0.0 Mil) and declined from Dec. 2023 ($-0.0 Mil) to Dec. 2024 ($-0.0 Mil).
The historical data trend for Vericel's Other Stockholders Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vericel Annual Data | |||||||||||||||||||||
Trend | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | Dec24 | |||||||||||
Other Stockholders Equity | Get a 7-Day Free Trial |
![]() |
![]() |
- | - | - | - | - |
Vericel Quarterly Data | ||||||||||||||||||||
Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | Dec24 | |
Other Stockholders Equity | Get a 7-Day Free Trial |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
- | - | - | - | - |
Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity
Thank you for viewing the detailed overview of Vericel's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.
Dominick Colangelo | director, officer: President and CEO | 1000 WINTER ST., SUITE 2200, WALTHAM MA 02451 |
Jonathan Siegal | officer: Principal Accounting Officer | C/O VERICEL CORPORATION, 64 SIDNEY STREET, CAMBRIDGE MA 02139 |
Sean C. Flynn | officer: SVP, General Counsel | C/O VERICEL CORPORATION, 64 SIDNEY ST., CAMBRIDGE MA 02139 |
Kevin F Mclaughlin | director | C/O ACCELERON PHARMA INC., 128 SIDNEY STREET, CAMBRIDGE MA 02139 |
Zerbe Robert L Md | director | |
Paul K Wotton | director | C/O ANTARES PHARMA, INC., 707 EAGLEVIEW BOULEVARD, SUITE 414, EXTON PA 19341 |
Jonathan Mark Hopper | officer: Chief Medical Officer | 64 SIDNEY STREET, CAMBRIDGE MA 02139 |
Steven C Gilman | director | 110 HARTWELL AVENUE, LEXINGTON MA 02421 |
Mara Joseph Anthony Jr | officer: Chief Financial Officer | C/O VERICEL CORPORATION, 64 SIDNEY STREET, CAMBRIDGE MA 02139 |
Michael Halpin | officer: Chief Operating Officer | C/O VERICEL CORPORATION, 64 SIDNEY ST., CAMBRIDGE MA 02139 |
Lisa Wright | director | C/O VERICEL CORPORATION, 64 SIDNEY STREET, CAMBRIDGE MA 02139 |
Sandra Pennell | officer: VP and Corporate Controller | C/O VERICEL CORPORATION, 64 SIDNEY STREET, CAMBRIDGE MA 02139 |
Gerard J Michel | officer: CFO & VP , Corp. Development | 420 CHIPETA WAY, SALT LAKE CITY UT 84108 |
Daniel Orlando | officer: Chief Operating Officer | P.O. BOX 376, ANN ARBOR MI 48105 |
Alan L Rubino | director | PO BOX 376, LOBBY L., ANN ARBOR MI 48105 |
From GuruFocus
By GuruFocus News • 01-14-2025
By GuruFocus News • 02-27-2025
By GuruFocus News • 10-18-2024
By GuruFocus News • 12-06-2024
By Marketwired • 02-13-2025
By GuruFocus News • 11-07-2024
By GuruFocus News • 02-28-2025
By Marketwired • 03-04-2025
By GuruFocus News • 11-08-2024
By Marketwired • 08-26-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.